Roche Holding AG Total Liabilities and Share Holders Equity 2010-2023 | RHHBY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Roche Holding AG total liabilities and share holders equity from 2010 to 2023. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

Roche Holding AG Total Liabilities and Share Holders Equity 2010-2023 | RHHBY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Roche Holding AG total liabilities and share holders equity from 2010 to 2023. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

Related Stocks
Company Name	Market Cap
Eli Lilly (LLY)	$711.9B
Novo Nordisk (NVO)	$460.6B
Johnson & Johnson (JNJ)	$374.4B
AbbVie (ABBV)	$303.5B
Merck (MRK)	$252.6B
Novartis AG (NVS)	$212.3B
AstraZeneca (AZN)	$199.2B
Pfizer (PFE)	$142.4B
Sanofi (SNY)	$121.8B
Innoviva (INVA)	$1.2B